AcquiSci Inc is a US-based medical technology company developing a novel therapeutic platform, d-OSAB™, for treating ischemic stroke and exploring applications in Chronic Heart Failure. Our device-based technology reduces inflammation surrounding brain clots for up to 12 hours, offering a significant expansion of the treatment window beyond current standards.

We focus on providing innovative solutions for neurological disorders, leveraging our anti-inflammatory platform to address the underlying causes of stroke and other inflammatory conditions.

AcquiSci’s core expertise lies in the development and refinement of d-OSAB™, a unique technology with the potential to transform stroke treatment and expand into broader therapeutic areas. We are committed to advancing medical innovation and improving patient outcomes through targeted therapies.

d-OSAB™ Disposables | AcquiSci Inc.

Product description

AcquiSci Inc. Newark, United States (US)

Price: N/A

AcquiSci Inc.
Newark, United States (US)